Start | Browse by Day | Author Index | Personal Scheduler

Parameterizing FDA’s Risk Assessment Models Using Spatio-temporal Data Acquired from Field Trials and Targeted Environmental Sampling

Monday, July 23, 2012: 10:30 AM
Room 551 (Rhode Island Convention Center)
David Oryang, U.S. Food and Drug Administration-CFSAN, College Park, MD
Back to: Making a Difference: Data Collection for Risk Assessments through Innovative Approaches
<< Previous Abstract | Next Abstract >>